HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.

Abstract
Familial dysautonomia (FD) is an autosomal recessive neurodegenerative disorder. The most prevalent causative mutation is a T-->C transition in a donor splice site of the IKBKAP transcript, resulting in aberrant splicing and a truncated protein. The mutation's position and leaky nature suggested that its impact might be moderated by altering the level of splice-regulating proteins. The reported ability of (-)-epigallocatechin gallate (EGCG), a polyphenol, to down-regulate the expression of hnRNP A2/B1, a trans-activating factor that encourages the use of intron-distal 5(') splice sites, prompted an evaluation of its effect on the IKBKAP transcript in FD-derived cells. EGCG reduces the level of hnRNP A2/B1 and increases the amounts of the wild-type IKBKAP-encoded transcript and functional protein. Combined treatment of cells with EGCG and tocotrienol, which upregulates IKBKAP transcription, results in a synergistic production of the functional gene product. These findings suggest the possible use of EGCG as a therapeutic modality for individuals with FD.
AuthorsSylvia L Anderson, Jinsong Qiu, Berish Y Rubin
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 310 Issue 2 Pg. 627-33 (Oct 17 2003) ISSN: 0006-291X [Print] United States
PMID14521957 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Elp1 protein, human
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B
  • RNA, Messenger
  • Tocotrienols
  • Transcriptional Elongation Factors
  • Catechin
  • epigallocatechin gallate
Topics
  • Base Sequence
  • Carrier Proteins (genetics, metabolism)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Line
  • Drug Synergism
  • Dysautonomia, Familial (genetics, metabolism)
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B (genetics, metabolism)
  • Humans
  • Molecular Sequence Data
  • Mutation
  • RNA Splicing (drug effects)
  • RNA, Messenger (chemistry, metabolism)
  • Tocotrienols (pharmacology)
  • Transcriptional Elongation Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: